8-K: Reviv3 Procare Company Appoints Three New Directors Ahead of NYSE American Listing

Reviv3 Procare Company has appointed three new directors to its board, effective upon the company's expected listing on the NYSE American Stock Exchange.

Summary

• Reviv3 Procare Company has appointed Jeffrey Brown, Peter Dunne, and Manu Ohri to its Board of Directors.
• The appointments are effective upon the company's expected listing on the NYSE American Stock Exchange.
• Mr. Brown's term will expire at the 2024 annual meeting of stockholders, while Messrs. Dunne and Ohri's terms will expire at the 2025 annual meeting.
• Messrs. Dunne and Ohri will also serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
• The new directors were not selected under any prior arrangement or understanding with any other person.
• There are no known transactions with the new directors that require disclosure under Item 404(a) of Regulation S-K.
• Messrs. Dunne and Ohri will participate in the company's standard non-employee director compensation arrangements.
• Upon the NYSE American Listing, Messrs. Dunne and Ohri will each receive a Restricted Stock Award of 5,000 shares, vesting after one year.

Sentiment

Score: 7

Explanation: The document is generally positive, indicating progress towards a key milestone (NYSE American listing) with the appointment of new directors. However, it also includes cautionary language about risks and uncertainties.

Positives

• The appointment of three new directors adds expertise and oversight to the board.
• The new directors bring experience to the Audit, Compensation, and Nominating and Corporate Governance Committees.
• The granting of restricted stock awards aligns the new directors' interests with those of the company and its shareholders.

Risks

• The NYSE American Listing is not guaranteed and is subject to various risks and uncertainties.
• The forward-looking statements in the report are not guarantees of future performance and involve risks and uncertainties.

Future Outlook

The company's future is tied to the successful listing on the NYSE American Stock Exchange, which is subject to various risks and uncertainties.

Management Comments

• The company is proceeding with the appointment of new directors in anticipation of the NYSE American Listing.
• The company does not assume the obligation to update any forward-looking statement, except as required by applicable law.

Industry Context

The appointment of new directors is a common practice for companies preparing for a stock exchange listing, aiming to enhance corporate governance and investor confidence.

Comparison to Industry Standards

• The appointment of independent directors to key committees like Audit, Compensation, and Nominating is a standard practice for publicly listed companies.
• The use of restricted stock awards as part of director compensation is also a common practice to align director interests with shareholder value.

Management Changes

Stakeholder Impact

• Shareholders will likely view the appointment of new directors as a positive step towards the company's growth and governance.
• Employees may see the listing as a sign of company progress and stability.

Next Steps

• The company will proceed with the NYSE American Listing.
• The new directors will assume their roles upon the listing.

Key Dates

Keywords

Board of Directors, NYSE American Listing, Corporate Governance, Director Appointment, Restricted Stock Award, Audit Committee, Compensation Committee, Nominating Committee